HF1029 (Legislative Session 94 (2025-2026))
Heritable or congenital disorder revision of lists of tests required to be administered for determination of presence.
Related bill: SF1494
AI Generated Summary
The legislative bill H.F. No. 1029 is aimed at revising and updating the list of medical tests required to detect heritable or congenital disorders in Minnesota. This bill mandates the Commissioner of Health to periodically update this list, incorporating new medical advancements and testing methods that can improve public health outcomes. The decisions on which tests to administer will consider several factors, including the reliability of the test, the treatability of the disorder, and the severity of the health conditions that could arise from the disorders.
Specific changes proposed by the bill include: - Empowering the commissioner to periodically update the testing list as medical science progresses. - Any updates to the testing list need advisory committee recommendations, commissioner's approval, and publication in the State Register. - The bill simplifies the process by exempting these revisions from the usual rulemaking procedures found in chapter 14 of Minnesota statutes.
The bill also specifically adds testing for metachromatic leukodystrophy (MLD) to the list of mandatory screenings.
Overall, the bill is intended to keep Minnesota's health screenings for heritable and congenital disorders in line with the latest medical practices and to ensure timely updates without undergoing the standard, more lengthy rulemaking processes.
Bill text versions
- Introduction PDF file
Actions
Date | Chamber | Where | Type | Name | Committee Name |
---|---|---|---|---|---|
February 16, 2025 | House | Floor | Action | Introduction and first reading, referred to | Health Finance and Policy |
February 18, 2025 | House | Floor | Action | Authors added | |
February 23, 2025 | House | Floor | Action | Author added | |
March 25, 2025 | House | Floor | Action | Author added |
Citations
[ { "analysis": { "added": [ "A requirement to include metachromatic leukodystrophy (MLD) in the list of tests." ], "removed": [], "summary": "This bill amends the determination of tests for heritable or congenital disorders under section 144.125.", "modified": [ "Processes for revising the test list, including exemptions from rulemaking requirements." ] }, "citation": "144.125" }, { "analysis": { "added": [], "removed": [], "summary": "Reference to the advisory committee for test list recommendations under section 144.1255.", "modified": [ "Role of the advisory committee in recommending test list changes." ] }, "citation": "144.1255" }, { "analysis": { "added": [], "removed": [], "summary": "Exemption from rulemaking requirements specified in section 14.385.", "modified": [ "Exemption clause for revisions to the list of tests." ] }, "citation": "14.385" }, { "analysis": { "added": [], "removed": [], "summary": "Exemption from rulemaking requirements specified in section 14.386.", "modified": [ "Exemption clause for revisions to the list of tests." ] }, "citation": "14.386" } ]